|
SkyePharma Moves To 2010 Pretax Profit, Sees Cash Outflows
Wall Street Journal LN) Wednesday said it swung to a 2010 pretax profit, but it expects substantial cash outflows in 2011 relating to the planned European launch of its flagship asthma treatment Flutiform in the second half of the year. The company also said it expects … |
View full post on asthma – Google News